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Abstract
Background: Aspiration of subglottic secretions past the endotracheal tube (ETT) cuff is a prerequisite for
developing ventilator-associated pneumonia (VAP). Subglottic secretion drainage (SSD) ETTs reduce aspiration of
subglottic secretions and have demonstrated lower VAP rates. We compared the performance of seven SSD ETTs
against a non-SSD ETT in preventing aspiration below inflated cuffs.
Methods: ETTs were positioned vertically in 2 cm diameter cylinders. Four ml of a standard microbial suspension
was added above inflated cuffs. After 1 h, aspiration was measured and ETTs demonstrating no leakage were
subjected to rotational movement and evaluation over 24 h. Collected aspirated fluid was used to inoculate agar
media and incubated aerobically at 37 °C for 24 h. The aspiration rate, volume and number of microorganisms that
leaked past the cuff was measured. Experiments were repeated (×10) for each type of ETT, with new ETTs used for
each repeat. Best performing ETTs were then tested in five different cylinder diameters (1.6, 1.8, 2.0, 2.2 and 2.4 cm).
Experiments were repeated as above using sterile water. Volume and time taken for aspiration past the cuff was
measured. Experiments were repeated (×10) for each type of ETT. Results were analysed using non-parametric tests
for repeated measures.
Results: The PneuX ETT prevented aspiration past the cuff in all experiments. All other ETTs allowed aspiration, with
considerable variability in performance. The PneuX ETT was statistically superior in reducing aspiration compared to
the SealGuard (p < 0.009), KimVent (p < 0.002), TaperGuard (p < 0.004), Lanz (p < 0.001), ISIS (p < 0.001), SACETT (p < 0.
001) and Soft Seal (p < 0.001) ETTs. Of the 4 ETTs tested in differing cylinder sizes, the PneuX significantly reduced
aspiration across the range of diameters compared to the SealGuard (p < 0.0001), TaperGuard (p < 0.0001) and
KimVent (p < 0.0001) ETTs.
Conclusions: ETTs showed substantial variation in fluid aspiration, relating to cuff material and design. Variability in
performance was likely due to the random manner in which involutional folds form in the inflated ETT cuff. The
PneuX ETT was the only ETT able to consistently prevent aspiration past the cuff in all experiments.
Keywords: Ventilator-associated pneumonia, Nosocomial pneumonia, Endotracheal tube cuff, Endotracheal tube,
Pulmonary aspiration
Background
In the Intensive Care Unit (ICU), ventilator associated
pneumonia (VAP) is the commonest infective nosoco-
mial cause of mortality. In addition to the reports of
mortality directly attributable to VAP, VAP increases the
duration of mechanical ventilation, length of stay and
cost [1]. A prerequisite for developing VAP is aspiration
of subglottic secretions past the endotracheal tube
(ETT) cuff, the extent of which is dependent on the
ETT design [2, 3].
The inflated ETT cuff seals the airway, allowing venti-
lation to only occur though the tube lumen, and
prevents movement of air and fluid around the ETT [4].
However, the ETT subverts the patient’s normal pulmon-
ary defence mechanisms, including mucociliary clear-
ance and the cough reflex [2, 5]. After intubation, the
ETT, oropharyngeal surfaces and secretions rapidly be-
come colonised with pathogenic bacteria [2, 6]. Gastric
contents reflux into the oropharynx, mix with these
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secretions [7] and accumulate above the cuff. If the
airway seal is compromised, aspiration of these secre-
tions occurs [4]. High bacterial load, with chemical and
enzymatic injury from gastric secretions, [3] can over-
whelm pulmonary defences leading to microbial colon-
isation of the lower respiratory tract and VAP. One
study showed that the bacteria in subglottic secretions
were identical to the causative agents of VAP in 70% of
patients [8]. Therefore, correctly achieving and main-
taining the airway seal is critical in preventing VAP.
Conventionally, ETTs have high-volume, low-pressure
(HVLP) cuffs [9]. The fully inflated HVLP ETT cuff
diameter is larger than the adult trachea [10], and this
design prevents tracheal mucosal injury by allowing the
pressure within the cuff to be equal to the tracheal wall
pressure. Therefore, the cuff is only partially inflated,
even when correct pressures are used. The excess mater-
ial folds and causes involutions, causing channels to de-
velop (Fig. 1) [9]. These channels facilitate aspiration of
subglottic secretions into the lungs. It is widely accepted
that aspiration occurs for all HVLP ETTs to varying de-
grees [11] and this has been consistently demonstrated
in in vitro and clinical studies [10, 12–17].
Manufacturers have redesigned their ETTs and cuffs in
order to prevent aspiration of subglottic secretions. For
example, ETTs have been developed that allow removal
of subglottic fluids, thereby reducing the available vol-
ume of secretions entering the lungs. These subglottic
secretion drainage (SSD) ETTs, have demonstrated lower
VAP rates [12, 18–24]. Other ETTs use novel cuff mate-
rials to reduce the number or size of channels [25], vari-
ations to the cuff shape, employ devices to continuously
maintain cuff pressure [26] or employ antibacterial coat-
ings [27]. However, in ETT design, manufacturers must
account for the variability in the size and shape of
human tracheas. Tracheas are tapered and exhibit di-
mensional variability. The anterior-posterior (AP) tra-
cheal diameter ranges between 1.27-2.38 cm for women
and 1.68-2.86 cm for men [28]. Selecting the correct size
ETT for patients is subjective and determined on the pa-
tient’s sex, height or weight [29]. The wrong size can
cause tracheal ischemia (if too large) or facilitate aspir-
ation (if too small) [29]. A recent study identified an in-
verse relationship between tracheal size and body mass
index [30], highlighting potential difficulties in making
accurate assessments. Therefore, ETTs need to account
for anatomical variation and safeguard the trachea.
This in vitro study aimed to compare ‘new generation’
ETTs in the prevention of aspiration of fluids past the cuff
in ‘tracheal’ models. Experiments used microbial suspen-
sions to highlight passage of microorganisms past the cuff,
and a physiological range of model ‘tracheas’ to determine
whether size affected the degree of microaspiration.
Methods
Aspiration of microbiological fluids
Preparation of microorganisms
Test microorganisms were Pseudomonas aeruginosa
ATCC 15692, Staphylococcus aureus NCIB 9518 and
Candida albicans ATCC 90027. Bacteria and Candida
were cultured on blood or Sabouraud’s dextrose agar, re-
spectively. Microorganisms were subcultured and grown
overnight (18 h) in Tryptic Soy Broth at 37 °C. Cells
were harvested by centrifugation, and the pellets washed
in phosphate buffered saline (PBS). This was repeated
(×2) and microorganisms were re-suspended in PBS to a
turbidity of 0.1 OD. One ml of each bacterial and can-
dida suspension was combined and added to 1 ml of
PBS to produce a 4 ml inoculum. On each experimental
day, a starting concentration equating to 0.1 OD was
used. To minimise variation in the number of viable
cells between experiments on different occasions, the
same number of colonies were inoculated into Tryptic
Soy Broth and incubated for the same period of time
(18 h) before preparation and adjustment in PBS.
ETT model
A ‘model trachea’ was developed (Fig. 2a) by aseptically
connecting the tip of a 20 ml syringe barrel (Becton
Dickinson Plastipak, County Louth, Ireland) to a 10 ml
enteral syringe (barrel and plunger) (Enteral UK,
Yorkshire, UK). The 20 ml syringe barrel, representing
the trachea had a 2 cm internal diameter into which the
ETT was placed and the enteral syringe was used to
capture the aspirated secretions. Seven ETTs (8.0 mm)
with design variations to prevent leakage of subglottic
secretions and a standard non-SSD ETT (8.0 mm) were
selected for testing (Table 1).
Fig. 1 A high-volume-low-pressure cuff inflated to 30 cmH20 inside a
2.0 cm ‘trachea’. The blue dye is placed above the inflated cuff to
demonstrate aspiration of fluid past the cuff. Despite inflating the ETT
cuff to the correct tracheal wall pressure, it is only partially inflated with
excess material folding and causing involutions. The blue dye
highlights the formation of channels, which allow leakage of subglottic
fluid into the lungs overhead view (a) and a lateral view (b)
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Assessment of aspiration
Experiments were conducted at 37 °C in a temperature
and humidity controlled environment. The distal cuffed
ETT was aseptically placed inside the 20 ml syringe bar-
rel and the cuff inflated to the correct pressure using a
hand-held manometer (Portex, Smiths Medical Inter-
national Ltd, Kent, UK) according to the manufacturer’s
instructions. If continuous cuff pressure monitors were
recommended, these were used to maintain cuff inflation
during experiments.
Four ml of standardised microbial suspension was
added above the ETT cuff. The time taken for the fluid
to leak past the ETT cuff was measured. Any fluid that
leaked past the cuff within 1 h, was collected in the en-
teral syringe and this was recorded as a tube leak. In
cases of no observed fluid leak, a standard movement
test (140° axial rotation, to mimic oral care movements)
was applied to the proximal end of the ETT after the ini-
tial 1 h period at 0, 15, 30 and 45 min. If no leak was
evident after the movement tests, the enteral syringe was
disconnected from the tip of the 20 ml syringe barrel,
aseptically filled with 4 ml of sterile PBS and re-con-
nected to the tip of the 20 ml syringe barrel. The 4 ml
sterile PBS was then injected into the 20 ml syringe below
the inflated ETT cuff. The PBS was withdrawn and the
fluid processed to determine potential ‘micro leaks’.
The collected microbial fluid was serially decimal di-
luted in PBS. Fifty μl of the diluted suspensions were
plated on to Tryptone Soya Agar and incubated aerobic-
ally at 37 °C for 24 h. The resulting number of colony
forming units (cfu) were then counted. Experiments
were repeated (×10) for each ETT type and new ETTs
were used for each repeat.
ETTs that did not leak during any of the static or
movement tests were subjected to a 24 h static test. Ex-
periments were repeated (×3), with new ETTs used for
each repeat.
Effect of ‘tracheal size’ on aspiration
The 4 ‘best performing’ ETTs from the microbiological
study were analysed in these experiments. Model
tracheas were developed using rigid glass cylinders, with
internal diameters of 1.6, 1.8, 2.2 and 2.4 cm (Dabble
Labs UK, Kent UK) (Fig. 2b). For the 2.0 cm sized ‘tra-
chea’ diameter, the syringe model described above (and
shown in Fig. 2a) was utilised. ETTs were positioned ver-
tically and the study was conducted as outlined above.
However, in these studies, 4 ml of sterile water (B. Braun
Melsungen AG, Melsungen, Germany) was added above
the ETT cuff. The volume and time taken for leakage
past the cuff was measured. Experiments were con-
ducted over a 1 h period. If no aspiration was observed,
a standard movement test was applied to the proximal
ETT as previously described. Experiments were repeated
(×10) for each tracheal size.
Statistic analysis
Statistical analysis was performed using the R Project
Model for statistical analysis (The R Foundation, 2014).
Aspiration of microbiological fluids
Results were analysed using ANOVA analysis and a
Tukey multiple comparison of the means. This test
compared the overall performance of all ETTs in pre-
venting aspiration of microbial fluids past the cuff
and compared the volume (ml/min) and quantity of
cfu that leaked past the cuff over time (cfu/min). Fur-
ther analysis was performed using non-parametric
statistical tests for repeated measures using a pairwise
Mann–Whitney U Test.
Fig. 2 a The in vitro trachea model used in the aspiration of microbial
fluid study. The 20 ml syringe was connected to the 10 ml enteral
syringe via the tip. The endotracheal tube was placed in the 20 ml
syringe. Fluid leaking past the cuff was collected aseptically in the enteral
syringe. b the in vitro trachea model used in the range of tracheas study.
The endotracheal tube was placed inside the rigid glass ‘trachea’ and the
fluid leaked past the cuff was collected inside the model
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Effect of ‘tracheal size’ on aspiration
Results were analysed using non-parametric statistical ana-
lysis for repeated measures and stratifying by size of the
glass trachea using the Wilcoxon-Nemenyi-McDonald-
Thompson test [31], comparing the ETTs and the fluid
volume leaked past the cuff (ml/min).
Results
Aspiration of microbiological fluids
Aspiration was expressed as total cfu/min and volume of
fluid leaked past the cuff. With the exception of the PneuX
ETT, all ETTs demonstrated leakage of microorganisms
past the cuff. The Portex Soft Seal, Lanz, ISIS and
SACETT ETTs leaked 4 ml of microbial fluid on all occa-
sions (between <5 min and 1 h). The SealGuard, KimVent
and TaperGuard ETTs leaked on some occasions and these
were analysed in the movement test. Once rotation was
applied, aspiration of bacterial fluid occurred with all
TaperGuard and KimVent ETTs and on some occasions
with the SealGuard ETT. The PneuX ETT was the only
ETT that progressed to the 24 h test. There was no macro
or microaspiration of microorganisms past the cuff with
Table 1 Properties of the ETTs used in the study and the novel technologies used to prevent aspiration of subglottic secretions
ETT and cuff
pressure monitor
Manufacter
Portex, Smiths
Medical, Kent, UK
Venner, Jo Koon
Circle, Singapore
Mallinckrodt, Covidien Massachusetts, USA Kimberly-Clark,
Georgia, USA
Teleflex UK,
Athione,
Ireland
ETT Portex Soft Seal
® Cuff Tracheal
Tube
Portex SACETT™
Suction Above
ET Cuff
Venner™ PneuX
P.Y.™ ETT
Mallinckrodt™
SealGuard™
Evac Endotracheal Tube
Mallinckrodt™
TaperGuard™
Evac Oral
Endotracheal Tube
Mallinckrodt™ Hi-Lo
Oral Endotracheal
Tube, Lanz System
KimVent™ MICROCUFF™
Subglottic Suctioning
Endotracheal Tube
Teleflex ISIS®
HVT™
Cuff type HVLP HVLP LVLP HVLP HVLP HVLP HVLP HVLP
Cuff material PVC PVC Silicone Poly-urethane PVC PVC Poly-urethane PVC
Cuff shape Cylindrical Tapered Cylindrical Tapered Tapered Cylindrical Cylindrical elongated Tapered
Cuff resting
diameter (cm)
3 3 Dependent on
tracheal size
2.7 2.54 3.3 3 2.8
Recommended
Cuff Pressure
(cm H20)
30 30 80 (=30) 20-30 20-30 25-33 20-30 20-30
Subglottic port(s) 0 1 3 1 1 0 1 1, detachable
Cuff pressure
monitor
No Pressure Easy Tracheal Seal
Monitor
No No Lanz valve inflated
to 30-34 cm H2O
No No
Fig. 3 Aspiration of microbial fluid study. ETTs used in the study are shown on the x-axis and include the results of the 24 h study. a Log of
colony forming units aspirated past the cuff for each ETT. b Volume of fluid leaked past the ETT on a logarithmic scale. Results demonstrate that
the PneuX ETT was the only tube that prevented aspiration of bacteria in the static, movement and 24 h study. Variability of the results occurred
between repeats of the HVLP ETTs
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the PneuX ETT in the stationary, movement or 24 h
experiments (Fig. 3).
ANOVA analysis demonstrated a significant difference
between all of the studied ETTs when comparing micro-
bial fluid leakage (p < 0.00001). The PneuX ETT did not
allow aspiration in any experiment and therefore, non-
parametric statistical analysis for repeated measures was
used to compare all other ETT results against the PneuX
ETT. The PneuX ETT demonstrated significantly re-
duced aspiration compared to the SealGuard (p < 0.009),
KimVent (p < 0.002), TaperGuard (p < 0.004), Lanz (p <
0.001), ISIS (p < 0.001), SACETT (p < 0.001) and Soft
Seal (p < 0.001) ETTs.
Correlation
A liner correlation between volume and cfu/min leaking
past the cuff was demonstrated, correlation co-efficient
0.826, p < 0.0001 (Fig. 4). This high correlation allowed
volume of fluid to be used as a surrogate for bacterial
load in the effect of ‘tracheal size’ on aspiration
experiments.
Effect of ‘tracheal size’ on aspiration
The 4 ETTs (PneuX, SealGuard, KimVent and Taper-
Guard ETTs) subjected to the movement test in the
microbiological study were selected for testing using dif-
ferent sized ‘trachea models’. Aspiration was expressed
as volume of fluid leaked past the cuff.
With the exception of the PneuX ETT, all ETTs dem-
onstrated leakage of fluid past the cuff across the differ-
ent trachea sizes. Of the trachea sizes tested, the ‘best’
diameters for the SealGuard and TaperGuard ETTs were
the 2.0 and 2.2 cm, and for the KimVent ETT it was
2.4 cm (Fig. 5). Since the PneuX ETT demonstrated no
aspiration of fluid past the cuff for any tracheal size
non-parametric statistical analysis for repeated measures
was again used to compare all other ETT results against
the PneuX ETT. The PneuX ETT was found to signifi-
cantly reduce fluid aspiration compared with the Seal-
Guard (p < 0.0001), TaperGuard (p < 0.0001) and KimVent
(p < 0.0001) ETTs.
Discussion
Aspiration of pathogenic subglottic secretions past the
ETT cuff is a recognised risk factor for VAP [9]. All
HVLP ETT cuffs form channels allowing aspiration of
subglottic secretions [11]. Manufacturers have rede-
signed aspects of their ETTs to limit this. These studies
compared 8 ETTs in preventing aspiration past the cuff
in terms of microorganisms and fluid volume. Selected
ETTs required a novel design incorporated to prevent
subglottic fluid aspiration, with the exception of the
Portex Soft Seal, which is one of the commonest ETT in
clinical use in the UK.
In this study, all HVLP ETT cuffs exhibited leakage of
microbial fluids past the cuff. Only the PneuX ETT (low
volume, low pressure (LVLP) cuff ), consistently pre-
vented aspiration of fluid under all test conditions (Fig. 3
and 5, 6). Aspiration of microorganisms occurred in all
experiments with the Lanz, ISIS, SACETT and Soft Seal
ETTs. Results were variable in terms of leaked volume,
rate of leakage and microbial aspiration. With the
SealGuard, TaperGuard and the KimVent ETTs, some
tubes permitted aspiration almost immediately, some
progressed to the movement study and some did not
leak after manipulation. Similar results were seen for the
‘trachea size’ study, where performance was also variable.
The variation within the same type of ETTs, likely re-
lates to the manner in which folds develop within the
cuff during inflation, which appears to be random
Fig. 4 Correlation between volume leaked past the cuff and number of CFU count. Correlation co-efficient = 0.826, p < 0.0001
Mariyaselvam et al. BMC Anesthesiology  (2017) 17:36 Page 5 of 9
(Fig. 6). This was highlighted in the movement study,
where upon manipulation, the folds in the cuffs that had
originally formed in such a way to prevent leakage in the
static model moved, enabling a fluid pathway to develop
thus allowing leakage of fluid. The variability in perform-
ance evident in these studies could lead to unpredictable
results in clinical practice. A recent clinical study re-
ported that the KimVent, TaperGuard and SealGuard
ETTs were not superior to a standard ETT in preventing
tracheal colonisation or VAP [17]. Indeed, our results in
this in vitro model would have predicted that in a clin-
ical trial [17], where expected duration of ventilation
Fig. 5 Effect of tracheal size (1.6, 1.8, 2.0, 2.2 and 2.4 cm) on aspiration (volume of fluid) past the cuff per hour. The PneuX ETT was the only tube
that prevented the aspiration of fluid at each tracheal size. Variability of the results was evident for each HVLP ETT
Fig. 6 Aspiration of fluid (blue dye) past the cuff and differences in channel formation seen with each ETT cuff. (a) Portex Soft Seal ® Cuff Tracheal
Tube, (b) The Venner™ PneuX P.Y. ™ ETT (c) Mallinckrodt™ SealGuard™ Evac Endotracheal Tube, (d) KimVent™ MICROCUFF Subglottic Suctioning
Endotracheal Tube, (e) MallinckrodtTM Tapergurad™ Evac Oral Endotracheal Tube, (f) Mallinckrodt™ Hi-Lo Oral Endotracheal Tube, Mallinckrodt™
Lanz System, (g) Teleflex ISIS® HVT™ and (h) SACETT™ Suction Above ET Cuff
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was greater than 48 h the KimVent, TaperGuard and
SealGuard ETTs would have not have performed better
than a standard ETT in preventing VAP.
Certain HVLP cuff designs are reported to reduce the
rate of aspiration and prevent VAP [10, 12–16]. Ultra-thin
polyurethane cuffs (wall thickness 7–10 μm) develop finer
folds; thereby reduce the rate of aspiration, but not pre-
vent it [13, 32] and this was evident in this study with the
KimVent and SealGuard ETTs, which leaked slowest and
lowest volumes. Tapered cuffs have reportedly shown
benefit over cylindrical cuffs [14, 33]. In this study the
TaperGuard and SealGuard ETTs performed better than
most HVLP ETTs. However, both the tapered ISIS and
SACETT ETT cuffs made of polyvinylchloride, permitted
aspiration on all occasions. Polyvinylchloride cuffs (wall
thickness 50 μm) [9] develop larger folds which allow
greater aspiration of subglottic secretions. This may indi-
cate that cuff material is of greater importance than cuff
shape in terms of preventing leakage [32]. The combin-
ation, seen in the SealGuard ETT, appears to afford
greater protection, as this was the best performing HVLP
ETT in this study.
Studies show that maintaining cuff pressure correctly
reduces the incidence of VAP [34]. In this study the
Lanz and SACETT ETTs were used with their recom-
mended cuff pressure monitors, however their perform-
ance was not superior to the Soft Seal ETT. Maintaining
correct cuff pressure is important however this study
showed that the properties of the ETT cuff may be
equally important in preventing aspiration.
The PneuX ETT consistently prevented aspiration in
all experiments. The LVLP cuff of the PneuX ETT is
made of highly elastic silicone and uniformly inflates
until the correct tracheal wall pressure is achieved at the
required tracheal circumference, hence, the cuff does
not develop folds (Fig. 6) [35]. The PneuX ETT used a
tracheal seal monitor, designed to maintain the pressure
of the silicone cuff at the appropriate pressure at all
times, even during movement [35] and this was demon-
strated in this study. Our results replicate previous in
vitro studies which demonstrate no leakage past the cuff
for the PneuX ETT and superior performance when
compared to other ETT examined [10, 36]. Our findings
are also supported by a recent publication by Chenelle
et al., which demonstrated leakage in a different bench
model [37]. In their study, Chenelle et al., showed leak-
age occurred with all HVLP cuffs tested and was pre-
vented by the PneuX cuff [37]. Our study confirms and
builds on this data, by testing all the SSD ETT currently
available and also examines the quantification of the
bacterial load which the lungs may be exposed to. Com-
monly, in vitro studies have used water to demonstrate
leakage past the cuff [10, 12, 32, 37]. Our study is novel
in its use of a microbial solution, which was used to
simulate the presence of pathogenic organisms com-
monly found in the subglottic space. The species used
were frequent causative agents of VAP [6, 8]. Clinically
microbial counts of 1 × 104 cfu/ml from bronchoalveolar
lavages are indicative of VAP [38]. In this study, the mi-
crobial solution was equivalent to ca. 107 cells/ml. Al-
though higher than typically encountered clinically,
this served to enhance discrimination and sensitivity
of the experiments. In experiments where no visible
aspiration was seen, the space below the cuff was irri-
gated to determine whether micro-leaks occurred and
in this study, no microaspiration of microorganisms
were detected.
In initial experiments, the correlation between cfu/min
and volume leaked past the cuff was demonstrated and
volume of fluid was therefore used as a surrogate for
bacterial load in the ‘trachea size’ study. It was important
to test ETTs across a range of trachea sizes, due to the
considerable anatomical variability [28]. One may argue
that clinicians would not use a size 8.0 ETT in patients
with 1.6 or 2.4 cm tracheas. However, patients are not
routinely scanned to assess tracheal size prior to intub-
ation and studies have shown the inaccuracies in clini-
cians assessing tracheal size [30]. Using a size 8.0 ETT
in this range of trachea sizes, represents rigorous bench
testing and better comparison to clinical practice and
anatomical variation.
Many clinical trials with novel ETTs aimed at preventing
VAP often show disappointing results. These are costly,
time consuming and often fail to replicate in vitro results
[39]. Our study tested 8 ETTs across a range of ‘trachea’
sizes, included movement tests and extended durations to
increase robustness. ETTs that appear to prevent aspir-
ation in bench tests should be subjected to pilot in-patient
studies, where primary outcome measures of aspiration
are biomarkers such as pepsin, amylase and bacterial
counts [40, 41]. This would demonstrate the adequacy of
an ETT to prevent aspiration and would also allow larger
clinical trials to be adequately powered.
Conclusions
Prevention of aspiration past the ETT cuff is a prerequis-
ite for averting VAP. In these investigations, variation in
the efficacy of HVLP ETTs was apparent and likely due
to the random manner in which folds develop in the
cuff. The PneuX ETT was the only ETT to consistently
prevent aspiration past the cuff in all experiments. The
PneuX ETT should be further evaluated in patients using
biomarkers of aspiration to determine whether these
results are replicated clinically.
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